ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HTFL vs HAE // EV/EBITDA & P/E VALUATION

Heartflow Inc. (NASDAQ) VS. Haemonetics Corporation (NYSE) • 15-METRIC TALLY: HTFL 4 — HAE 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HTFL VS. HAE) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HTFL HAE SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.80% 59.00% +17.80 HTFL /gross-margins <GO>
Return on Invested Capital (ROIC) -12.00% 8.40% -20.40 HAE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 32.5x — TIE /valuation <GO>
Free Cash Flow Yield -1.12% 4.78% -5.90 HAE /fcf-yield <GO>
Operating Margin -36.40% 11.70% -48.10 HAE /operating-margins <GO>
Net Profit Margin -60.00% 0.00% -60.00 HAE /net-margins <GO>
Revenue Growth (YoY) 39.90% -2.00% +41.90 HTFL /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 26.00 3.89 +22.11 HTFL /balance-sheet <GO>
Piotroski F-Score Quality 5/9 7/9 -2.00 HAE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 64.0 63.0 +1.00 HTFL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 1.00 -0.10 HAE /macro-sensitivity <GO>
Forward P/E Multiple 27.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.13B $5.44B -$309.1M HAE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HTFL REV HAE REV HTFL GROSS % HAE GROSS % HTFL FCF HAE FCF
FY 2025 $176.0M $1.33B 76.8% 59.0% -$59.0M $260.4M
FY 2024 $125.8M $1.36B 75.1% 55.0% -$73.4M $142.4M
FY 2023 $87.2M $1.31B — — -$80.4M $122.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HTFL // BETA 0.90
HAE // BETA 1.00